JP6388877B2 - 有害な心臓状態を有する被験者の改善された心臓イメージングのためのシステムおよび方法 - Google Patents
有害な心臓状態を有する被験者の改善された心臓イメージングのためのシステムおよび方法 Download PDFInfo
- Publication number
- JP6388877B2 JP6388877B2 JP2015553768A JP2015553768A JP6388877B2 JP 6388877 B2 JP6388877 B2 JP 6388877B2 JP 2015553768 A JP2015553768 A JP 2015553768A JP 2015553768 A JP2015553768 A JP 2015553768A JP 6388877 B2 JP6388877 B2 JP 6388877B2
- Authority
- JP
- Japan
- Prior art keywords
- delay
- module
- roi
- inversion
- saturation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003384 imaging method Methods 0.000 title claims description 38
- 230000000747 cardiac effect Effects 0.000 title claims description 37
- 238000000034 method Methods 0.000 title claims description 35
- 230000002411 adverse Effects 0.000 title description 3
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 claims description 52
- 230000005415 magnetization Effects 0.000 claims description 42
- 238000013507 mapping Methods 0.000 claims description 27
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 18
- 238000011084 recovery Methods 0.000 claims description 16
- 238000002059 diagnostic imaging Methods 0.000 claims description 15
- 230000002107 myocardial effect Effects 0.000 claims description 12
- 230000010287 polarization Effects 0.000 claims description 7
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 4
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 4
- 230000003111 delayed effect Effects 0.000 claims description 3
- 229910052594 sapphire Inorganic materials 0.000 claims 2
- 239000010980 sapphire Substances 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 14
- 206010003119 arrhythmia Diseases 0.000 description 13
- 230000006793 arrhythmia Effects 0.000 description 12
- 231100000241 scar Toxicity 0.000 description 10
- 206010016654 Fibrosis Diseases 0.000 description 8
- 230000004761 fibrosis Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 230000036278 prepulse Effects 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- 208000032544 Cicatrix Diseases 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000002075 inversion recovery Methods 0.000 description 6
- 230000037387 scars Effects 0.000 description 6
- 206010003658 Atrial Fibrillation Diseases 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 230000006978 adaptation Effects 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000005284 excitation Effects 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- 238000004891 communication Methods 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 206010006322 Breath holding Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010048858 Ischaemic cardiomyopathy Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000013184 cardiac magnetic resonance imaging Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5602—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution by filtering or weighting based on different relaxation times within the sample, e.g. T1 weighting using an inversion pulse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/004—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
- A61B5/0044—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7285—Specific aspects of physiological measurement analysis for synchronising or triggering a physiological measurement or image acquisition with a physiological event or waveform, e.g. an ECG signal
- A61B5/7289—Retrospective gating, i.e. associating measured signals or images with a physiological event after the actual measurement or image acquisition, e.g. by simultaneously recording an additional physiological signal during the measurement or image acquisition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/50—NMR imaging systems based on the determination of relaxation times, e.g. T1 measurement by IR sequences; T2 measurement by multiple-echo sequences
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/567—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution gated by physiological signals, i.e. synchronization of acquired MR data with periodical motion of an object of interest, e.g. monitoring or triggering system for cardiac or respiratory gating
- G01R33/5676—Gating or triggering based on an MR signal, e.g. involving one or more navigator echoes for motion monitoring and correction
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Signal Processing (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Power Engineering (AREA)
- Pulmonology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
Description
本出願は、2013年1月16日に出願された「SYSTEM AND METHOD FOR IMPROVED CARDIAC IMAGING OF SUBJECTS WITH ADVERSE CARDIAC CONDITIONS」と題する米国特許出願第13/742,620号に基づき、それに対する優先権を主張し、参照によりその全体を本明細書に組み込む。
この核磁気共鳴(NMR)現象が利用される多種多様な測定シーケンスがある。
Claims (20)
- パルスシーケンスを使用して造影剤が投与された被験者の心周期に不一致がある前記被験者の画像を取得する磁気共鳴イメージング(MRI)システムを制御するための方法であって、前記方法は、
前記造影剤が投与された被験者の心周期における所定の点の識別情報を受信するステップと、
前記心周期における前記所定の点が現れたことが識別されると、前記所定の点の前からの関心領域(ROI)内の磁化をディフェーズするように構成されている飽和モジュールを実行するステップと、
前記ROI内のスピンを反転させるように構成されている反転モジュールを実行するステップと、
前記被験者から医療イメージングデータを取得するステップと、
前記飽和モジュールの前記実行と前記反転モジュールの前記実行との間に遅延を挿入するステップと、を含み、
前記遅延の継続時間は、前記飽和モジュールを用いて、前記ROIにおける組織の磁化履歴を制御することによって、前記被験者の前記心周期における不一致の前記医療イメージングデータにおける痕跡を制御するように構成される
ことを特徴とする方法。 - 前記被験者の前記心周期における前記所定の点を識別するためにナビゲータイメージング取得を実行するステップをさらに含むことを特徴とする請求項1に記載の方法。
- 前記反転モジュールは、非選択的反転パルスを含み、前記遅延は、前記飽和モジュールの完了から前記医療イメージングデータを取得するまでの飽和時間(Tsat)から、前記反転モジュールの完了から前記医療イメージングデータを取得するまでの反転時間(Tinv)を差し引いた時間に等しいことを特徴とする請求項1に記載の方法。
- 前記飽和モジュール、前記反転モジュール、および前記遅延は、一定のTsatおよびTinvで、前記心周期内の前記所定の点が現れる毎に反復されることを特徴とする請求項3に記載の方法。
- 前記遅延は、前記ROI内の組織の前記T1がTinv後のT'=T1・log(2)において無効化されるという仮定に基づいて選択されることを特徴とする請求項5に記載の方法。
- 前記ROIは前記被験者の心臓を含み、前記飽和モジュール、前記反転モジュール、および前記遅延は、ROI内の健康な心筋組織からの信号を無くするように選択されることを特徴とする請求項1に記載の方法。
- 前記パルスシーケンスはT1マッピングパルスシーケンスを含み、前記飽和モジュールおよび前記遅延は、心周期間の縦磁化の回復期間の長さを制御するように構成されていることを特徴とする請求項3に記載の方法。
- 磁気共鳴イメージング(MRI)システムであって、
前記MRIシステム内に配置された被験者の少なくとも一部分の周囲に分極磁場を生成するように構成されている磁石システムと、
前記分極磁場に対する少なくとも1つの傾斜磁場を確立するように構成されている複数の傾斜磁場コイルと、
RFパルスを生成し、前記MRIシステム内に配置された被験者から医療イメージングデータを取得するように構成されている無線周波数(RF)システムと、
前記磁石システム、前記複数の傾斜磁場コイル、および前記RFシステムの動作を制御するように構成されているコンピュータシステムであって、それによって、
前記被験者の心周期における所定の点を識別し、
前記心周期における前記所定の点の前記識別に基づいて、関心領域(ROI)内の磁化をディフェーズするように構成される飽和モジュールを実行する前記RFシステムを制御し、
後続する前記反転モジュールの実行の間に遅延を実行し、
遅延の実行後に、前記ROI内のスピンを反転させるように構成されている反転モジュールを実行するように前記RFシステムを制御し、
前記ROIから医療イメージングデータを取得するように前記傾斜磁場コイルおよび前記RFシステムを制御する、コンピュータシステムと、を備え、
前記飽和モジュールは非選択的飽和パルスを含み、前記関心領域(ROI)を含む容積の磁化全体をディフェーズするよう構成され、
前記遅延の継続時間は、前記飽和モジュールのパラメータに基づいて、前記心周期上の前記ROIにおける組織の磁化履歴を制御することによって、前記被験者の前記心周期における不一致の前記医療イメージングデータにおける痕跡を制御するように選択される
ことを特徴とするシステム。 - 前記コンピュータシステムは、前記被験者の前記心周期における前記所定の点を識別するためにナビゲータイメージング取得を実行するようにさらに構成されていることを特徴とする請求項11に記載のシステム。
- 前記反転モジュールは、非選択的反転パルスを含み、前記遅延は、前記飽和モジュールの完了から前記医療イメージングデータを取得するまで延伸する飽和時間(Tsat)から、前記反転モジュールの完了から前記医療イメージングデータを取得するまでの反転時間(Tinv)を差し引いた時間に等しいことを特徴とする請求項11に記載のシステム。
- 前記飽和モジュール、前記反転モジュール、および前記遅延は、一定のTsatおよびTinvで、前記心周期内の前記所定の点が現れる毎に反復されることを特徴とする請求項13に記載のシステム。
- 前記コンピュータシステムは、前記遅延を、前記ROI内の組織の前記T1がTinv後のT'=T1・log(2)において無効化されるという仮定に基づいて選択するように構成されていることを特徴とする請求項15に記載のシステム。
- 前記パルスシーケンスはT1マッピングパルスシーケンスを含み、前記飽和モジュールおよび前記遅延は、心周期間の縦磁化の回復期間の長さを制御するように構成されていることを特徴とする請求項11に記載のシステム。
- 前記ROIは前記被験者の心臓を含み、前記飽和モジュール、前記反転モジュール、および前記遅延は、ROI内の健康な心筋組織からの信号を無くするように選択されることを特徴とする請求項11に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/742,620 US10531812B2 (en) | 2013-01-16 | 2013-01-16 | System and method for improved cardiac imaging of subjects with adverse cardiac conditions |
US13/742,620 | 2013-01-16 | ||
PCT/US2014/011287 WO2014113322A1 (en) | 2013-01-16 | 2014-01-13 | System and method for improved cardiac imaging of subjects with adverse cardiac conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016502927A JP2016502927A (ja) | 2016-02-01 |
JP6388877B2 true JP6388877B2 (ja) | 2018-09-12 |
Family
ID=50070678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015553768A Expired - Fee Related JP6388877B2 (ja) | 2013-01-16 | 2014-01-13 | 有害な心臓状態を有する被験者の改善された心臓イメージングのためのシステムおよび方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10531812B2 (ja) |
EP (1) | EP2805174A1 (ja) |
JP (1) | JP6388877B2 (ja) |
KR (1) | KR20150118952A (ja) |
CN (1) | CN105283774B (ja) |
WO (1) | WO2014113322A1 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013218281B4 (de) * | 2013-09-12 | 2016-02-25 | Siemens Aktiengesellschaft | Verbesserte MR-Aufnahmesequenz zum Erstellen einer T1-Karte |
CN104808161B (zh) * | 2014-01-27 | 2018-11-02 | 西门子(深圳)磁共振有限公司 | 磁共振成像方法和装置 |
US9931082B2 (en) | 2015-07-31 | 2018-04-03 | General Electric Company | Time optimal phase sensitive inversion recovery reconstruction for magnetic resonance imaging |
KR101820302B1 (ko) * | 2015-12-21 | 2018-01-19 | 삼성전자주식회사 | 자기 공명 영상 장치 및 그 제어 방법 |
US10451700B2 (en) | 2016-09-08 | 2019-10-22 | Regents Of The University Of Minnesota | System and method for reducing partial voluming artifacts in quantitative myocardial tissue characterization |
WO2018144573A1 (en) * | 2017-01-31 | 2018-08-09 | Regents Of The University Of Minnesota | System and method for producing temporally resolved images depicting late-gadolinium enhancement with magnetic resonance imaging |
GB2565788B (en) * | 2017-08-22 | 2020-01-01 | Siemens Healthcare Gmbh | A method of performing magnetic resonance imaging and a magnetic resonance apparatus |
JP7074982B2 (ja) * | 2019-04-19 | 2022-05-25 | 学校法人杏林学園 | 磁気共鳴イメージング装置、画像処理装置及び画像処理方法 |
CN111352054B (zh) * | 2020-03-31 | 2020-10-13 | 浙江大学 | 一种振荡梯度准备的3d梯度自旋回波成像方法及设备 |
CN113796849A (zh) * | 2020-06-17 | 2021-12-17 | 首都医科大学附属北京安贞医院 | 一种跨心动周期的图像数据采集设备 |
US11740306B2 (en) * | 2021-11-30 | 2023-08-29 | Shanghai United Imaging Healthcare Co., Ltd. | Systems and methods for magnetic resonance T1 mapping |
CN117558428B (zh) * | 2024-01-12 | 2024-03-22 | 华中科技大学同济医学院附属同济医院 | 一种用于肝脏mri的成像优化方法及系统 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908386A (en) * | 1995-12-14 | 1999-06-01 | Regents Of The Universotiy Of Minnesota | Fast MRI for assessment of myocardial perfusion with arrythmia insensitive magnetization preparation |
US6219571B1 (en) * | 1998-04-06 | 2001-04-17 | Board Of Trustees Of The Leland Stanford Junior University | Magnetic resonance imaging using driven equilibrium fourier transform |
US7561909B1 (en) * | 2002-09-16 | 2009-07-14 | The United States Of America As Represented By The Department Of Health And Human Services | MRI navigator methods and systems |
US7257383B2 (en) * | 2004-03-08 | 2007-08-14 | Broadcom Corporation | Method and system for improving dynamic range for communication systems using upstream analog information |
JP2005278919A (ja) | 2004-03-30 | 2005-10-13 | Hitachi Medical Corp | 磁気共鳴イメージング装置 |
US20080081986A1 (en) * | 2006-09-29 | 2008-04-03 | General Electric Company | Method and apparatus for generating a magnetic resonance image |
JP2008086343A (ja) | 2006-09-29 | 2008-04-17 | Hitachi Medical Corp | 磁気共鳴撮影装置 |
WO2008070765A2 (en) * | 2006-12-06 | 2008-06-12 | Case Western Reserve University | Light-sensitive constructs for inducing cell death and cell signaling |
US8086297B2 (en) | 2007-01-31 | 2011-12-27 | Duke University | Dark blood delayed enhancement magnetic resonance viability imaging techniques for assessing subendocardial infarcts |
US8446148B2 (en) | 2008-08-29 | 2013-05-21 | Siemens Medical Solutions Usa, Inc. | Long T1 artifact suppression techniques for magnetic resonance imaging |
EP2352537A1 (en) * | 2008-11-03 | 2011-08-10 | Schering Corporation | Elastomeric discharge member for nasal delivery device |
CN102860827B (zh) | 2009-09-18 | 2017-05-17 | 东芝医疗系统株式会社 | 磁共振成像装置以及磁共振成像方法 |
JP2011092678A (ja) | 2009-09-30 | 2011-05-12 | Toshiba Corp | 磁気共鳴イメージング装置 |
US20120179028A1 (en) * | 2010-09-13 | 2012-07-12 | Peter Caravan | System and method for determining blood-brain barrier permeability to water |
US9081073B2 (en) * | 2011-01-27 | 2015-07-14 | Siemens Medical Solutions Usa, Inc. | System for suppression of artifacts in MR imaging |
JP5989977B2 (ja) * | 2011-07-29 | 2016-09-07 | キヤノン株式会社 | プリント装置および方法 |
US20130274592A1 (en) * | 2012-02-29 | 2013-10-17 | Taehoon SHIN | Time-resolved early-to-late gadolinium enhancement magnetic resonance imaging |
-
2013
- 2013-01-16 US US13/742,620 patent/US10531812B2/en active Active
-
2014
- 2014-01-13 EP EP14703468.0A patent/EP2805174A1/en not_active Withdrawn
- 2014-01-13 JP JP2015553768A patent/JP6388877B2/ja not_active Expired - Fee Related
- 2014-01-13 KR KR1020157022075A patent/KR20150118952A/ko not_active Application Discontinuation
- 2014-01-13 CN CN201480005146.3A patent/CN105283774B/zh not_active Expired - Fee Related
- 2014-01-13 WO PCT/US2014/011287 patent/WO2014113322A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20140200436A1 (en) | 2014-07-17 |
KR20150118952A (ko) | 2015-10-23 |
CN105283774B (zh) | 2019-03-15 |
JP2016502927A (ja) | 2016-02-01 |
CN105283774A (zh) | 2016-01-27 |
US10531812B2 (en) | 2020-01-14 |
EP2805174A1 (en) | 2014-11-26 |
WO2014113322A1 (en) | 2014-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6388877B2 (ja) | 有害な心臓状態を有する被験者の改善された心臓イメージングのためのシステムおよび方法 | |
US9835705B2 (en) | System and method for free-breathing volumetric imaging of cardiac tissue | |
US8575933B2 (en) | Method for motion correction in magnetic resonance imaging using radio frequency coil arrays | |
Kim et al. | How we perform delayed enhancement imaging: HOW I DO… | |
US9395431B2 (en) | Multi-contrast delayed enhancement cardiac magnetic resonance imaging | |
US7047060B1 (en) | Multiple preparatory excitations and readouts distributed over the cardiac cycle | |
US7689263B1 (en) | Method and apparatus for acquiring free-breathing MR images using navigator echo with saturation RF pulse | |
US7561909B1 (en) | MRI navigator methods and systems | |
US10520570B2 (en) | System and method for tissue characterization using multislice magnetic resonance imaging | |
US20050245812A1 (en) | Acquiring contrast-enhanced, T1-weighted, cine magnetic resonance images | |
US8441257B2 (en) | Time resolved spin labeled MRI cineangiography | |
US7432706B2 (en) | Magnetic resonance imaging using blood flow navigation | |
KR101809213B1 (ko) | T2-이완 시간의 다중 슬라이스 영상화를 위한 방법 및 장치 | |
US8872515B2 (en) | System and method for diffusion-modulated relaxation magnetic resonance imaging | |
US8112145B2 (en) | MRI method for assessing myocardial viability | |
US20090149734A1 (en) | Diagnostic imaging apparatus, magnetic resonance imaging apparatus, and x-ray ct apparatus | |
US10557905B2 (en) | System and method for producing high-resolution magnetic relaxation parameter maps | |
US11313931B2 (en) | System and method for quantifying T1, T2 and resonance frequency using rosette trajectory acquisition and read segmented reconstruction | |
CN104013405B (zh) | 动态心肌活性检测方法和系统 | |
US8928317B2 (en) | System and method for controlling apparent timing dependencies for T2-weighted MRI imaging | |
US7693569B1 (en) | Method and system of determining motion in a region-of-interest directly and independently of k-space trajectory | |
US11079448B2 (en) | System and method for proton density mapping and receiver bias correction using magnetic resonance fingerprinting (MRF) | |
WO2024081779A2 (en) | Imaging slow flow dynamics of cerebrospinal fluid using magnetic resonance imaging | |
Shah et al. | Imaging of the heart: Myocardial imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161206 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171031 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171107 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180201 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20180206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180717 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180815 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6388877 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |